Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Urothelial Carcinoma (UC)”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more
Exelixis 1,314
Testing effectiveness (Phase 2)Ended earlyNCT02334527
What this trial is testing

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

Who this might be right for
Metastatic Urothelial Carcinoma (UC)
UNC Lineberger Comprehensive Cancer Center 12
Early research (Phase 1)Enrolling By InvitationNCT07353294
What this trial is testing

Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC

Who this might be right for
Bladder Urothelial CarcinomaLymph Node Metastasis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 12
Testing effectiveness (Phase 2)Study completedNCT03390595
What this trial is testing

Avelumab Plus Carboplatin-gemcitabine in Urothelial Carcinoma

Who this might be right for
Metastatic Urothelial Cancer
Associació per a la Recerca Oncologica, Spain 85
Not applicableNot Yet RecruitingNCT07629700
What this trial is testing

Study of Peripheral Neuropathy in Patients With Advanced Urothelial Cancer Treated With Enfortumab Vedotin and Pembrolizumab With Supportive Neuridase (ENDEAVOR)

Who this might be right for
Urothelial Carcinoma (UC)Peripheral Nerve Disease
University of Florence 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06632951
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)

Who this might be right for
Urothelial Carcinoma
AbbVie 150
Testing effectiveness (Phase 2)Ended earlyNCT03311334
What this trial is testing

DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Urothelial CarcinomaPrimary Peritoneal Cancer+3 more
Sumitomo Pharma America, Inc. 47
Early research (Phase 1)Active Not RecruitingNCT05393427
What this trial is testing

BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Urinary TumorsOther Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 4
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
ITM Oncologics GmbH 270
Not applicableApproved For MarketingNCT04136808
What this trial is testing

An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Locally Advanced or Metastatic Urothelial Carcinoma (UC)
Astellas Pharma Global Development, Inc.
Early research (Phase 1)Ended earlyNCT05069935
What this trial is testing

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Fate Therapeutics 16
Very early researchLooking for participantsNCT07439120
What this trial is testing

Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors

Who this might be right for
Urothelial Carcinoma (UC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 10
Testing effectiveness (Phase 2)Study completedNCT04570410
What this trial is testing

Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial Carcinoma

Who this might be right for
Bladder Urothelial Carcinoma
The First Affiliated Hospital with Nanjing Medical University 30
Not applicableActive Not RecruitingNCT06412848
What this trial is testing

JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study

Who this might be right for
Urothelial Carcinoma
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 360
Large-scale testing (Phase 3)Study completedNCT03374488
What this trial is testing

Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carcinoma

Who this might be right for
UC (Urothelial Cancer)
Incyte Corporation 84
Testing effectiveness (Phase 2)Looking for participantsNCT04724018
What this trial is testing

Sacituzumab Govitecan Plus EV in Metastatic UC

Who this might be right for
Urothelial CancerMetastatic Urothelial CarcinomaMetastatic Urothelial Carcinoma of the Renal Pelvis and Ureter+1 more
Dana-Farber Cancer Institute 106
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631884
What this trial is testing

Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

Who this might be right for
Solid TumorsNeoplasms (Cancer / Tumors)Advanced Malignant Solid Neoplasm+13 more
Haihua Yuan 15
Testing effectiveness (Phase 2)UnknownNCT03745911
What this trial is testing

Paclitaxel and TAK-228 in Urothelial Carcinoma

Who this might be right for
Metastatic Urothelial Cancer
Associació per a la Recerca Oncologica, Spain 52
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Early research (Phase 1)Active Not RecruitingNCT04606472
What this trial is testing

SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Load More Results